VORICOFUNGAL 200 MG 10 F.C.TABS.(N/A YET)

Indication For the treatment of esophageal candidiasis invasive pulmonary aspergillosis and serious fungal infections caused by Scedosporium apiospermum and Fusarium spp. Mechanism of action Voriconazole binds and inhibits ergosterol synthesis by inhibiting CYP450-dependent 14-alpha sterol demethylase. The inhibition of 14-alpha sterol demethylase results in a depletion of ergosterol in fungal cell membrane.